Bayer Investors Push Court for Final Approval of $38M Settlement

0
26

No Admission of Wrongdoing

A Bayer spokesperson said Friday the company denies wrongdoing but is “pleased” to put the litigation behind it.

Counsel for the investors declined to comment.

Representing the investors are Carol V. Gilden, Steven J. Toll, Christopher Lometti, and Benjamin F. Jackson of Cohen Milstein Sellers & Toll PLLC, along with Nicole Lavallee and Alexander S. Vahdat of Berman Tabacco.

Signup for the USA Herald exclusive Newsletter

Bayer and its executives are defended by Jordan Eth and David J. Wiener of Morrison Foerster LLP and William Savitt, Noah B. Yavitz, and Emily R. Barreca of Wachtell Lipton Rosen & Katz.